IDO1 and cancer: This review discusses our understanding of IDO regulation, highlights mechanisms utilized by cancers to control IDO activity in the tumor immune microenvironment, and outlines pharmacological strategies for reversing these processes to ultimately augment our immunotherapeutic strategies for managing cancer patients.